Gastroscopy
Conditions
Interventions
Experimental group:esketamine
Sponsors
Beijing Children's Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
8 Years to 25 Years
Inclusion criteria
Inclusion criteria: 1. Subjects aged 8-18 years; 2. American Society of Anesthesiologists (ASA) risk score I-II; 3. BMI 18-25 kg/m2; 4. Children receiving painless gastroenteroscopy; 5. Before the start of any activities related to the trial, the subject's legal guardian signs the informed consent, has a full understanding of the purpose and significance of the trial, and is willing to abide by the trial protocol.
Exclusion criteria
Exclusion criteria: 1. Allergy to the study drug; 2. Children with serious risk of elevated blood pressure or intracranial pressure; 3. Patients with poorly controlled or untreated hypertension; 4. Children with untreated or undertreated hyperthyroidism (hyperthyroidism); 5. Children with known congenital heart disease and cardiovascular and cerebrovascular diseases; 6. Children with a history of elevated intraocular pressure or puncture eye injury; 7. Children with a history of asthma; 8. Children with mental system diseases and cognitive dysfunction; 9. Children with uncontrolled epilepsy; 10. Subjects who opt out of participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative propofol dose; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative awakening time of the child;Number of intraoperative body movements;Postoperative pain score;Incidence of adverse reactions; | — |
Countries
China
Contacts
Public ContactGao Zhengzheng
Beijing Children's Hospital, Capital Medical University
Outcome results
None listed